Last reviewed · How we verify
Natrium/ Kalium/ Magnesium sulfate
This combination of sodium, potassium, and magnesium sulfates acts as an osmotic laxative and electrolyte replacement therapy.
This combination of sodium, potassium, and magnesium sulfates acts as an osmotic laxative and electrolyte replacement therapy. Used for Constipation (osmotic laxative effect), Electrolyte supplementation and repletion.
At a glance
| Generic name | Natrium/ Kalium/ Magnesium sulfate |
|---|---|
| Sponsor | Tomas Bata Hospital, Czech Republic |
| Drug class | Osmotic laxative / Electrolyte supplement |
| Modality | Small molecule |
| Therapeutic area | Gastroenterology / Electrolyte management |
| Phase | FDA-approved |
Mechanism of action
The sulfate salts work by drawing water into the intestinal lumen through osmotic action, promoting bowel evacuation. Simultaneously, the formulation provides electrolyte supplementation to maintain or restore normal serum levels of sodium, potassium, and magnesium, which are essential for cellular function, nerve conduction, and muscle contraction.
Approved indications
- Constipation (osmotic laxative effect)
- Electrolyte supplementation / repletion
Common side effects
- Diarrhea
- Abdominal cramping
- Nausea
- Electrolyte imbalance (if overused)
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: